These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5369027)

  • 21. [Levels of properdin in the serum of rats submitted to the combined effect of zymosan and thio-TEPA].
    Bass-Shadkhan KhF
    Klin Lech Zlokach Novoobraz; 1968; 11():227-36. PubMed ID: 4972953
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. II].
    Venuti A; Gioffre' MA; Micali B; Caputo G
    Chir Patol Sper; 1982 Aug; 29(4):167-71. PubMed ID: 7172846
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental studies on the dosage-time relationship in cytostatic "stosstherapy"].
    Berndt F; Schmähl D
    Dtsch Med Wochenschr; 1968 Aug; 93(35):1656-8. PubMed ID: 5666892
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of low dose radium emanation of Yoshida sarcoma in the rat].
    Karrer K; Henn O
    Strahlentherapie; 1969 Oct; 138(4):481-8. PubMed ID: 5352497
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ineffectiveness of CH 23 in Yoshida sarcoma of the rat and mouse sarcoma 180].
    Schmähl D; Ballweg H; Berndt F; Osswald H
    Arzneimittelforschung; 1968 May; 18(5):588-9. PubMed ID: 5755887
    [No Abstract]   [Full Text] [Related]  

  • 27. Cathepsins inhibit growth of Yoshida ascites sarcoma in rat.
    Allegretti N; Andreis I; Kopitar M; Lebez D
    Nat New Biol; 1971 Feb; 229(6):180-1. PubMed ID: 4102010
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromosomal studies with the nitrogen mustard-sensitive and resistant Yoshida tumour.
    Ujházy V
    Neoplasma; 1968; 15(6):657-61. PubMed ID: 5704185
    [No Abstract]   [Full Text] [Related]  

  • 29. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxygen cytotoxicity in tumour cells.
    Bozzi A; Mavelli I; Mondovi B; Strom R; Rotilio G
    Bull Eur Physiopathol Respir; 1981; 17 Suppl():267-71. PubMed ID: 7248576
    [No Abstract]   [Full Text] [Related]  

  • 31. [Microchemical method for the determination of properdin].
    Pfordte K
    Z Gesamte Exp Med Einschl Exp Chir; 1966; 140(4):294-302. PubMed ID: 5991291
    [No Abstract]   [Full Text] [Related]  

  • 32. A new asparaginase-free inhibitor found in the guinea pig properdin fraction active against mouse tumour cells II. Interaction with Ehrlich's tumour in vitro and Gardner's lymphoma in vivo.
    Oravec C; Cambelová J
    Neoplasma; 1970; 17(2):111-23. PubMed ID: 5425388
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nonspecific stimulus therapy and the properdin system].
    Reissmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(2):125-31. PubMed ID: 4167542
    [No Abstract]   [Full Text] [Related]  

  • 34. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. I. Preparation of pea seed lectin-methotrexate derivative and the preliminary experiments.
    Slavík K; Bures L; Svihovcová P; Kronrád L
    Neoplasma; 1985; 32(4):415-9. PubMed ID: 4047253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of nitrogen mustard sensitive and resistant Yoshida sarcomas. II. Effect of treatment on cell kinetics.
    Ball CR; Connors TA; Cooper EH; Topping NE
    Neoplasma; 1967; 14(3):253-64. PubMed ID: 6063004
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiation-induced changes in the properdin system of the dog and a critical analysis of the general problem.
    Michaelson SM; Shively JN; Haydock IC
    Radiat Res; 1966 May; 28(1):60-70. PubMed ID: 5931752
    [No Abstract]   [Full Text] [Related]  

  • 38. Substances with antineoplastic effect. XLII. The influence of MBA on incorporation of some amino-acids in the proteins of Yoshida ascites rat sarcoma cells.
    Veselá H; Kraus P; Semonský M; Slavíková V
    Neoplasma; 1970; 17(1):49-52. PubMed ID: 5423433
    [No Abstract]   [Full Text] [Related]  

  • 39. [Agglutination titer of isoagglutinins in blood serum in cases of malignant neoplasms following zymosan stimulation].
    Dobrek A; Maciejewski B; Majewski S
    Pol Tyg Lek; 1975 Jan; 30(3):93-6. PubMed ID: 1110955
    [No Abstract]   [Full Text] [Related]  

  • 40. [Basic studies on methods of administering anticancerous agents].
    Takano H
    Zasshi Tokyo Ika Daigaku; 1967 Sep; 25(5):629-62. PubMed ID: 5625990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.